Literature DB >> 20847508

A case of lymphomatoid granulomatosis-like lung lesions with abundant infiltrating IgG4-positive plasma cells whose serum IgG4 levels became high following the start of corticosteroid therapy.

Tomoko Miyashita1, Katsunobu Yoshioka, Tomoyuki Nakamura, Yuki Kubo, Takeshi Inoue, Takashi Morikawa, Keiichi Ishii, Keiko Yamagami.   

Abstract

A 59-year-old man with a history of prostate hyperplasia was admitted to our hospital for further examination of a lung mass and renal dysfunction. Lung biopsy specimens revealed that inflammatory cells had infiltrated into the blood vessel walls. We initially suspected lymphomatoid granulomatosis, but Epstein Barr virus-encoded small RNA was negative. However, 50% of the infiltrating plasma cells were positive for IgG4. Furthermore, the kidneys and prostate contained abundant IgG4-positive plasma cells. He was diagnosed with IgG4-related sclerosing disease even though serum IgG4 levels were not elevated (45.7 mg/dL). Prednisolone reduced the lung masses and ameliorated renal function, but the serum IgG4 level increased (377 mg/dL). Seronegative IgG4-related sclerosing disease should be considered when patients present with such symptoms and treatment responses, and the secretion of IgG4 might be blocked by its active synthesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20847508     DOI: 10.2169/internalmedicine.49.3630

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  An initial exploration for comprehensive assessment of IgG4-related lung disease: analyses on the cases enrolled from a systematic review.

Authors:  An Wang; Jie Fan; Xiaofeng Chen; Shaohua Wang
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Thymic inflammatory pseudotumor with multilocular thymic cyst caused by immunoglobulin G4-related disease.

Authors:  Risa Oda; Katsuhiro Okuda; Takayuki Murase; Takuya Watanabe; Tadashi Sakane; Tsutomu Tatematsu; Keisuke Yokota; Hiroshi Haneda; Ryoichi Nakanishi
Journal:  Thorac Cancer       Date:  2018-11-23       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.